RecruitingNCT07517354

Family-Based Moyamoya Susceptibility and Early Detection

Studying Familial adult myoclonic epilepsy

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Beijing Tiantan Hospital
Intervention: 5T High-Resolution MRI(diagnostic_test)
Enrollment: 700 enrolled
Eligibility: All sexes
Timeline: 2024 – 2030

Study locations (1)

Beijing Hospital, Beijing, Beijing Municipality, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07517354 on ClinicalTrials.gov

Other trials for Familial adult myoclonic epilepsy

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGNCT07308860
Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended
Stanford University
RECRUITINGNCT05659485
Measuring Family Engagement in Care (The FAME Study)
Lady Davis Institute

See all trials for Familial adult myoclonic epilepsy →

← Back to all trials